LINC01194 recruits NUMA1 to promote ubiquitination of RYR2 to enhance malignant progression in triple-negative breast cancer

Duanyang Zhai(Sun Yat-sen University), Ying Lin(Sun Yat-sen University), Zhen Shan(Shenyang Medical College), Yuying Li(Ministry of Agriculture), Mengmeng Zhang(Nanjing Tech University), Xiaying Kuang(Sun Yat-sen University), Jiong Bi(Sun Yat-sen University), Nan Shao(Sun Yat-sen University)
Cancer Letters
June 21, 2022
10.1016/j.canlet.2022.215797
Cited by 18

Related Papers

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
|JAMA|2020|229
Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
|Cancer Cell International|2020|136
Lysine Restriction Affects Feed Intake and Amino Acid Metabolism via Gut Microbiome in Piglets
|Cellular Physiology and Biochemistry|2017|130
An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells
|Journal of the American College of Cardiology|2015|126
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
|Nature Medicine|2024|121